Rocket Doctor AI Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Rocket Doctor AI Inc. (Ticker: AIRDF) develops and provides AI-powered healthcare technology solutions, including clinical decision support tools, digital health platforms, and virtual care services that enhance patient access, physician efficiency, and healthcare outcomes across North America. Founded in 2018 and headquartered in Vancouver, British Columbia, Canada, the company offers core products such as the Global Library of Medicine (GLM), a proprietary AI-driven knowledge engine aggregating peer-reviewed clinical content for diagnostics and treatment recommendations; the Rocket Doctor digital health platform and marketplace, functioning as a "Shopify for physicians" with tools including Starship EMR for medical records and prescriptions, RD AI Connect for automated triage of over 20 chief complaints, RD AI Health Voyager for patient history summaries, and patient portals for appointment management; the Medical Education Suite (MES) for AI-powered clinical training and assessments; and the AI-Voice Nurse assistant for care support and mental health via voice interactions; alongside open APIs, chatbots, and the AI Pharmacy Assistant initiative for pharmaceutical sector integration. The company operates through subsidiaries including Treatment.com Inc., Rocket Doctor Inc., and Rocket Doctor US, serving physicians, health systems, medical students, and patients in Canada (provinces including British Columbia, Alberta, Ontario, New Brunswick) and the United States (states including California, New York, Minnesota), with a focus on rural, remote, underserved communities, Medicaid/Medicare members, and emergency department diversion programs. Recent developments include the April 2025 acquisition of Rocket Doctor Inc. for approximately C$11 million in shares plus contingent consideration, enabling first revenue quarter in Q2 2025 at $0.5 million with 89% gross margins, support for 300+ clinicians and 600,000+ patient visits, and payer agreements covering over 13 million insured members; a rebrand from Treatment.com AI Inc. to Rocket Doctor AI Inc. in August 2025; strategic partnerships such as with Central California Alliance for Health (450,000 members), EngageWell IPA backed by $1 million funding, and Georgian Bay General Hospital for virtual emergency care; deployment of MES to 240 University of Minnesota medical students; a late-2025 NIH SBIR grant award exceeding $500,000 USD to Treatment USA for medical history data enhancements; and a planned acquisition of Alea Health announced in November 2025 to expand AI mental health capabilities and GCC market presence.
Company News
Rocket Doctor AI Reports Strong Operational Momentum in Q2 2026 Driven by U.S. Expansion and Growing Patient Reach
Rocket Doctor Grants Equity
Rocket Doctor Enters New Strategic Network Agreement in California to Expand Access Across Multiple U.S. Healthcare Channels
Rocket Doctor AI Inc. Announces Non-Brokered Private Placement of Unsecured Convertible Debentures
Rocket Doctor Named One of Canada's Top 100 AI & Tech Startups for ALL IN 2026
Rocket Doctor Joins National Coalition Advocating for Permanent Medicare Telehealth
Rocket Doctor AI Inc. Appoints Financial Growth Strategist Andrew Lau as Chief Financial Officer to Help Accelerate U.S. Expansion
Rocket Doctor Enters into a Primary Care Value-Based Care Agreement in the United States, Expanding In-Network Coverage by More Than 5 Million Members
Rocket Doctor Partners with Mindstride to Expand Access to After-Hours Healthcare Across Ontario, Alberta and British Columbia
Rocket Doctor Grants Stock Options and RSUs
Rocket Doctor Grants Stock Options and RSUs
Rocket Doctor AI Announces Global Company Town Hall to Showcase 2025 Milestones; Q1 2026 Milestones and Strategic Vision
Rocket Doctor AI Announces Global Company Town Hall to Showcase 2025 Milestones; Q1 2026 Milestones and Strategic Vision
Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation
Rocket Doctor Inc. Selected to Join Canadian Life Sciences Trade Mission to New York and New Jersey
Rocket Doctor Amends 45 Degree Agreement
Rocket Doctor Amends 45 Degree Agreement
Rocket Doctor Strengthens Maryland Footprint with ~2 Million Additional Members Through a First In-Network Agreement with State Entity of a Major National Insurer
Rocket Doctor Announces Maryland Expansion and Strategic Appointment of New Medical Lead
Rocket Doctor Expands California Coverage with New In-Network Agreement with a National Insurer, Adding Over 2 Million Members